MétaGénoPolis

Pre-industrial demonstrator specialized in metagenomics for the investigation of the microbiota

MétaGénoPolis: Pre-industrial demonstrator specialized in metagenomics for the investigation of the microbiota

✔️ Presentation

▶️ MétaGénoPolis is a Research Unit of INRAE located at the Jouy-en-Josas Center and ISO 9001 certified. It implements automated techniques to explore at high resolution the genome of human bacteria present in the gut.

▶️ MétaGénoPolis is involved as a co-founder in the Million microbiome of humans project (MMHP), and in connection with the French Gut project on the mapping and understanding of the heterogeneity of healthy intestinal microbiota.

▶️ This component of the Health Pole of the CALIS research infrastructure hosts projects and collaborations in the pharmaceutical and agri-food sectors.

 

✔️ The members of MetaGenoPolis are as follows:

➡️ 1 executive director: Alexandre Cavezza

➡️ 4 scientific directors: Joël Doré (also SCIENTIFIC DIRECTOR OF MGP), Hervé Blottière (also DEPUTY SCIENTIFIC DIRECTOR OF METAFUN), Patrick Veiga (also DEPUTY SCIENTIFIC DIRECTOR OF SAMBO AND METAQUANT) and Mathieu Almeida (also DEPUTY SCIENTIFIC DIRECTOR OF METAQUANT AND IBS)

➡️ 1 team of industrial partnerships: Karine Valeille (BUSINESS DEVELOPER AND HEAD OF STRATEGIC PARTNERSHIPS), Florian Plaza-Onate (MICROBIOME DATA SCIENTIST), Florence Thirion (MICROBIOME DATA SCIENTIST), Anne-Sophie Alvarez (COMMUNICATION MANAGER), Sébastien Fromentin (MICROBIOME DATA SCIENTIST), Chloé Connan (PROJECT FOLLOW-UP MANAGER), Elliot Mathieu (OPERATIONAL MANAGER METAFUN), Pauline Govindin (IE Metafun), Aurélien Morat (AI Metafun), Mamadou Thiam (AI SAMBO), Marine Gilles (AI SAMBO)

➡️ 4 heads of technological platforms: Magali Berland (OPERATIONAL MANAGER OF METAQUANT/INFOBIOSTAT), Véronique Léjard (R&D MANAGER OF METAFUN), Elliot Mathieu (PRODUCTION MANAGER OF METAFUN), Christian Morabito (PRODUCTION MANAGER OF SAMBO)

 

✔️ Microbiome business developer:

Karine Valeille

 

✔️ European projects:

  • 2008-2012: MetaHIT (Human intestinal tract)
  • 2010-2014: EvoTAR (Antibiotic resistance)
  • 2012-2017: MetaCardis (Cardiometabolic diseases)
  • 2018-2023: HomoSymbiosus (Symbiosis)
  • 2018-2024: GEMMA (Autism)
  • 2018-2025: MicrobPredict (Liver diseases)

See also

Direct link of MétaGénoPolis: SEE HERE